Clinical Trial Update: Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis Disease [Phase 3]

View source ↗

Summary

This document reports an update on a Phase 3 clinical trial evaluating a shorter rifampicin-based treatment for people with less severe tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis
• Tuberculosis

Drugs mentioned

• Rifampicin

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Pulmonary TB | Phase 3 | Status: NOT_YET_RECRUITING